What is Kura Oncology's AOCI?

Kura Oncology (KURA) reported AOCI of -$380K in Q1 2026.

How has Kura Oncology's AOCI changed year-over-year?

Kura Oncology's AOCI decreased by 139.0% year-over-year, from $974K to -$380K.

What is the long-term trend for Kura Oncology's AOCI?

Over 5 years (2020 to 2025), Kura Oncology's AOCI has grown at a 86.0% compound annual growth rate (CAGR), from $46K to $1.02M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Kura Oncology KURA AOCI

AOCI at other companies

Johnson & JohnsonJNJ

-$14.83B-26.3%

AmgenAMGN

-$190M+17.7%

ExelixisEXEL

-$415K-121%

Syndax PharmaceuticalsSNDX

$11K-97.9%

AbbVieABBV

-$1.15B+33.8%

Corvus PharmaceuticalsCRVS

-$1.13M+10.2%

Other financials

Income statement

See full

Revenue$18.3M+29.5%

Gross profit$18.0M—

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

See full

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total equity$107.9M-70.4%

Total assets$652.6M-12.3%

Cash flow

See full

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

See full

Market cap$919.7M+81.6%

Enterprise value$904.89M+90.7%

P/S12.8×+3.5×

Profitability

See full

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

See full

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kura Oncology's AOCI?: Kura Oncology (KURA) reported AOCI of -$380K in Q1 2026.
How has Kura Oncology's AOCI changed year-over-year?: Kura Oncology's AOCI decreased by 139.0% year-over-year, from $974K to -$380K.
What is the long-term trend for Kura Oncology's AOCI?: Over 5 years (2020 to 2025), Kura Oncology's AOCI has grown at a 86.0% compound annual growth rate (CAGR), from $46K to $1.02M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.